TUBA1C and neoplasm: Some clinicopathological features were associated with poorer OS in a univariate Cox regression analysis (Table 1); these included advanced T stage (HR = 1.695, 95% CI = 1.1515–2.4949, p = 0.0074), advanced N stage (HR = 1.5312, 95% CI = 1.1646–2.0132, p = 0.0022), advanced overall tumor stage (HR = 1.7627, 95% CI = 1.2355–2.5147, p = 0.0017) and high expression of TUBA1C (HR = 1.0168, 95% CI = 1.0018–1.0320, P = 0.0278).